dr. dent on final lotus 2 findings from the lotus 2 trial in tnbc
Published 4 years ago • 294 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
1:22
dr. dent discusses the lotus trial in triple-negative breast cancer
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:34
dr. robert coleman on brca testing in ovarian cancer
-
1:42
dr. denduluri on the role of neoadjuvant therapy in her2 breast cancer
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
0:42
dr. pusztai on challenges with neoadjuvant her2 therapy
-
1:42
dr. dang on the destiny-breast01 trial in her2 metastatic breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
2:05
tropion-breast04: dato-dxd and durvalumab in tnbc or hr-low/her2- breast cancer
-
2:30
destiny-breast04: t-dxd in her2-low breast cancer regardless of molecular markers
-
2:00
tulip: trastuzumab duocarmazine improved pfs in pre-treated her2 breast cancer
-
1:04:09
drs. kuerer & mcarthur discuss the lastest #tnbc updates from #sso2022 - https://bit.ly/3ibs0zk
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
21:45
episode 2 journey to find the dense breast screening solution
-
14:24
optimisation of treatment selection & sequencing decisions in er /her2- breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
10:47
payer coverage of iv versus oral therapy in mbc